2022 annual financial data
Genmab 2022 Operating cash flow growth
Direct answer
Operating cash flow growth was 75.58%.
Operating income was 6,267,000,000 DKK and net income was 5,452,000,000 DKK.
Operating cash flow was 3,912,000,000 DKK.
Get free Genmab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,505,000,000 DKK
- Operating income
- 6,267,000,000 DKK
- Net income
- 5,452,000,000 DKK
- Operating cash flow
- 3,912,000,000 DKK